Free fatty acids inhibit adrenocorticotropin and cortisol secretion stimulated by physical exercise in normal men.
BACKGROUND
The basal circulating levels of ACTH and cortisol, but not the ACTH/cortisol response to hCRH, are significantly reduced by free fatty acid (FFA) infusion.


OBJECTIVE
To verify whether FFA infusion modifies the ACTH/cortisol response to physical exercise, a well-known activator of the HPA axis at suprapituitary level.


METHODS
Exercise tests on a bicycle ergometer during infusion of a lipid-heparin emulsion (LHE) (experimental test) or normal saline (NaCl 0.9%) (control test).


METHODS
Department of Cardiology at the University-Hospital.


METHODS
Seven healthy male subjects aged 25-33 years.


METHODS
On two mornings, at weekly intervals, LHE or saline were infused for 60 min; infusion started 10 min before exercise test on a bicycle ergometer, which lasted about 15 min.


METHODS
Circulating ACTH/cortisol levels and physiological variables during physical exercise.


RESULTS
FFA levels (0.4 +/- 0.1 mEq/l) remained constant during control test, whereas they progressively rose (peak at 60 min, 2.7 +/- 1.0 mEq/l) during LHE infusion. Neither basal nor exercise-induced changes in physiological variables were modified by LHE infusion. Both ACTH and cortisol increased during exercise, with peak levels at 20 min and 30 min (control test: 103% and 42%, P < 0.001; experimental test: 28.5% and 18.6%, P < 0.05 higher than baseline, respectively). Both ACTH and cortisol responses were significantly lower in the experimental than in the control test (at 20 min P < 0.002 and at 30 min P < 0.05 for ACTH; at 20 min P < 0.05 and at 30 min, 40 min and 50 min P < 0.001 for cortisol).


CONCLUSIONS
These data represent the first demonstration of an inhibitory action of increased circulating FFA levels on the HPA axis under stimulatory conditions (i.e. physical exercise, a challenge acting at suprapituitary level). In contrast, previous studies did not show FFA effects on the CRH-induced ACTH/cortisol response. Therefore, our data suggest negative effects of FFAs on the HPA axis at hypothalamic or higher centres in the central nervous system.
Coiro
V
V
Department of Internal Medicine and Biomedical Sciences, University of Parma, Parma, Italy. vittorio.coiro@unipr.it
Casti
A
A
Rubino
P
P
Manfredi
G
G
Maffei
M L
ML
Melani
A
A
Saccani Jotti
G
G
Chiodera
P
P
D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000378:metabolism*; D000328:Adult; D000704:Analysis of Variance; D003864:Depression, Chemical; D015444:Exercise / Q000502:physiology*; D005230:Fatty Acids, Nonesterified / Q000494:pharmacology*; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000378:metabolism*; D007262:Infusions, Intravenous; D008297:Male
D005230:Fatty Acids, Nonesterified; D000324:Adrenocorticotropic Hormone; D006493:Heparin; D006854:Hydrocortisone